OCTOFLEX
Live / Applied — Second extension granted (statement of use) (as of 12 Nov 2025)
What this means for you
Not registered yet, but its 01 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98627355
- Mark type
- Stylized text
- Filed
- 01 Jul 2024
- Published for opposition
- 24 Sept 2024
- Attorney of record
- Aaron W. Pederson
Goods and services
- Class 005 — Pharmaceuticals: Tizanidine hydrochloride for the treatment of neurological disorders, namely spasticity, pain and movement disorders
Owner
- Pharma Trademarks Inc., Cheyenne, WY, US
- Pharma Trademarks Inc., Cheyenne, WY, US
Prosecution history
- 12 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Nov 2025 — SOU EXTENSION 2 GRANTED
- 12 Nov 2025 — SOU EXTENSION 2 FILED
- 12 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 06 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 May 2025 — SOU EXTENSION 1 GRANTED
- 02 May 2025 — SOU EXTENSION 1 FILED
- 02 May 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Sept 2024 — PUBLISHED FOR OPPOSITION
- 04 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED